Literature DB >> 2835654

Identification of nonessential disulfide bonds and altered conformations in the v-sis protein, a homolog of the B chain of platelet-derived growth factor.

M K Sauer1, D J Donoghue.   

Abstract

The protein encoded by v-sis, the oncogene of simian sarcoma virus, is homologous to the B chain of platelet-derived growth factor (PDGF). There are eight conserved Cys residues between PDGF-B and the v-sis protein. Both native PDGF and the v-sis protein occur as disulfide-bonded dimers, probably containing both intramolecular and intermolecular disulfide bonds. Oligonucleotide-directed mutagenesis was used to change the Cys codons to Ser codons in the v-sis gene. Four single mutants lacked detectable biological activity, indicating that Cys-127, Cys-160, Cys-171, and Cys-208 are required for formation of a biologically active v-sis protein. The other four single mutants retained biological activity as determined in transformation assays, indicating that Cys-154, Cys-163, Cys-164, and Cys-210 are dispensable for biological activity. Double and triple mutants containing three of these altered sites were constructed, some of which were transforming as well. The v-sis proteins encoded by biologically active mutants displayed significantly reduced levels of dimeric protein compared with the wild-type v-sis protein, which dimerized very efficiently. Furthermore, a mutant with a termination codon at residue 209 exhibited partial transforming activity. This study thus suggests that the minimal region required for transformation consists of residues 127 to 208. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis indicated that the v-sis proteins encoded by some of the biologically active mutants exhibited an altered conformation when compared with the wild-type v-sis protein, and suggested that Cys-154 and Cys-163 participate in a nonessential disulfide bond.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835654      PMCID: PMC363243          DOI: 10.1128/mcb.8.3.1011-1018.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  Tertiary structural differences between microbial serine proteases and pancreatic serine enzymes.

Authors:  L T Delbaere; W L Hutcheon; M N James; W E Thiessen
Journal:  Nature       Date:  1975-10-30       Impact factor: 49.962

3.  The role of individual cysteine residues in the structure and function of the v-sis gene product.

Authors:  N A Giese; K C Robbins; S A Aaronson
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

4.  C-type virus in tumor tissue of a woolly monkey (Lagothrix spp.) with fibrosarcoma.

Authors:  G H Theilen; D Gould; M Fowler; D L Dungworth
Journal:  J Natl Cancer Inst       Date:  1971-10       Impact factor: 13.506

5.  The single-disulphide intermediates in the refolding of reduced pancreatic trypsin inhibitor.

Authors:  T E Creighton
Journal:  J Mol Biol       Date:  1974-08-15       Impact factor: 5.469

6.  Renaturation of the reduced bovine pancreatic trypsin inhibitor.

Authors:  T E Creighton
Journal:  J Mol Biol       Date:  1974-08-15       Impact factor: 5.469

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

Authors:  R Ross; J Glomset; B Kariya; L Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

9.  Catalysis by protein-disulphide isomerase of the unfolding and refolding of proteins with disulphide bonds.

Authors:  T E Creighton; D A Hillson; R B Freedman
Journal:  J Mol Biol       Date:  1980-09-05       Impact factor: 5.469

10.  A defined subgenomic fragment of in vitro synthesized Moloney sarcoma virus DNA can induce cell transformation upon transfection.

Authors:  P Andersson; M P Goldfarb; R A Weinberg
Journal:  Cell       Date:  1979-01       Impact factor: 41.582

View more
  11 in total

1.  Recent developments in the structure, function and regulation of platelet-derived growth factor and its receptors.

Authors:  J Tiesman; A Rizzino
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity.

Authors:  A L Cook; P M Kirwin; S Craig; L J Bawden; D R Green; M J Price; S J Richardson; A Fallon; A H Drummond; R M Edwards
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

3.  Expression and purification of biologically active v-sis/platelet-derived growth factor B protein by using a baculovirus vector system.

Authors:  N Giese; M May-Siroff; W J LaRochelle; K van Wyke Coelingh; S A Aaronson
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Immunochemical localization of the epitope for a monoclonal antibody that neutralizes human platelet-derived growth factor mitogenic activity.

Authors:  W J LaRochelle; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

5.  Cysteine mutants of herpes simplex virus type 1 glycoprotein D exhibit temperature-sensitive properties in structure and function.

Authors:  D Long; G H Cohen; M I Muggeridge; R J Eisenberg
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  A small v-sis/platelet-derived growth factor (PDGF) B-protein domain in which subtle conformational changes abrogate PDGF receptor interaction and transforming activity.

Authors:  N Giese; W J LaRochelle; M May-Siroff; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

7.  Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein.

Authors:  L Petti; L A Nilson; D DiMaio
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

8.  Crystal structure of human platelet-derived growth factor BB.

Authors:  C Oefner; A D'Arcy; F K Winkler; B Eggimann; M Hosang
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

9.  The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.

Authors:  K C Hart; Y F Xu; A N Meyer; B A Lee; D J Donoghue
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

10.  The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions.

Authors:  D J Goldstein; T Andresson; J J Sparkowski; R Schlegel
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.